Our verdict is Benign. The variant received -11 ACMG points: 2P and 13B. PM2BP4_StrongBP6_Very_StrongBP7
The NM_000038.6(APC):c.7194C>T(p.Ser2398Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000197 in 152,218 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
APC (HGNC:583): (APC regulator of WNT signaling pathway) This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Mutations in the APC gene have been found to occur in most colorectal cancers, where disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. [provided by RefSeq, Jun 2022]
APC Gene-Disease associations (from GenCC):
classic or attenuated familial adenomatous polyposis
Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
desmoid tumor
Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
familial adenomatous polyposis 1
Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
gastric adenocarcinoma and proximal polyposis of the stomach
Our verdict: Benign. The variant received -11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 5-112842788-C-T is Benign according to our data. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-112842788-C-T is described in CliVar as Benign/Likely_benign. Clinvar id is 215570.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.925 with no splicing effect.
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 10, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Familial adenomatous polyposis 1Benign:2
Apr 09, 2024
Myriad Genetics, Inc.
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. -
Nov 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not providedBenign:1
May 02, 2018
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Classic or attenuated familial adenomatous polyposisBenign:1
Aug 15, 2023
All of Us Research Program, National Institutes of Health
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
APC-related disorderBenign:1
Sep 21, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Hereditary cancer-predisposing syndromeBenign:1
Sep 30, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -